Valuation: Masimo Corporation

Market Cap 9.42B 8.07B 7.57B 6.91B 13.04B 898B 13.17B 89.25B 34.74B 453B 35.38B 34.61B 1,501B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.42B 7.89B 7.21B 13.61B 937B 13.74B 93.1B 36.24B 473B 36.91B 36.11B 1,566B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
3 months+0.64%
6 months+2.77%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 53.78
Extreme 53.78
305.21
Manager TitleAgeSince
President - 03/08/2026
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 10/06/2026
Date Insider Type Main position Quantity % Market Cap.
6/10/26 A Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
4/23/26 A Fiscal year

Chairman

3,569 0.0068%
3/6/26 A Free

Head of Human Resources

5,985 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+23.98%+62.48% 9.42B
+0.19%-0.12%+22.79%+29.01% 12.78B
-0.69%+1.12%+17.14%+29.93% 7B
-2.83%-1.46%+51.68%+32.43% 6.7B
-5.12%-2.27% - - 5.31B
-1.95%+12.88%-10.61%+67.52% 5.25B
+1.69%+1.58%-29.82%-21.10% 3.92B
+5.13%+2.20%+50.60%-40.81% 2.05B
+1.72%+5.50%+55.24%-8.94% 1.67B
+7.01%+5.45%-19.56%+135.29% 1.74B
Average +0.53%+1.89%+17.94%+31.76% 5.58B
Weighted average by Cap. -0.46%+1.24%+19.26%+35.51%

Financials

2024 2025
Net sales 2.09B 1.79B 1.68B 1.54B 2.9B 200B 2.93B 19.84B 7.72B 101B 7.86B 7.69B 334B 1.53B 1.31B 1.23B 1.12B 2.11B 146B 2.13B 14.46B 5.63B 73.44B 5.73B 5.61B 243B
Net income -305M -261M -245M -224M -422M -29.07B -426M -2.89B -1.12B -14.67B -1.14B -1.12B -48.57B -152M -130M -122M -111M -210M -14.44B -212M -1.43B -559M -7.29B -569M -556M -24.13B
Net Debt 668M 573M 537M 490M 925M 63.73B 934M 6.33B 2.46B 32.15B 2.51B 2.46B 106B 407M 349M 327M 299M 563M 38.8B 569M 3.85B 1.5B 19.58B 1.53B 1.49B 64.83B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock